KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Long-Term Debt Repayments (2016 - 2025)

Resmed (RMD) has disclosed Long-Term Debt Repayments for 17 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Repayments changed 0.0% year-over-year to $5.0 million, compared with a TTM value of $10.0 million through Dec 2025, down 98.2%, and an annual FY2025 reading of $40.0 million, down 95.21% over the prior year.
  • Long-Term Debt Repayments was $5.0 million for Q4 2025 at Resmed, roughly flat from $5.0 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $300.0 million in Q2 2024 and bottomed at $5.0 million in Q4 2024.
  • Average Long-Term Debt Repayments over 5 years is $103.6 million, with a median of $103.0 million recorded in 2021.
  • The sharpest move saw Long-Term Debt Repayments soared 766.67% in 2023, then crashed 98.33% in 2025.
  • Year by year, Long-Term Debt Repayments stood at $136.0 million in 2021, then tumbled by 88.97% to $15.0 million in 2022, then surged by 766.67% to $130.0 million in 2023, then plummeted by 96.15% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025.
  • Business Quant data shows Long-Term Debt Repayments for RMD at $5.0 million in Q4 2025, $5.0 million in Q2 2025, and $5.0 million in Q4 2024.